| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021891007 |
| P356 | DOI | 10.1186/1475-2875-10-103 |
| P932 | PMC publication ID | 3107817 |
| P698 | PubMed publication ID | 21518429 |
| P5875 | ResearchGate publication ID | 51075386 |
| P50 | author | Antonio Puyet | Q37382823 |
| Amalia Diez | Q37382845 | ||
| José M. Bautista | Q37382869 | ||
| Patricia Marín-García | Q37382801 | ||
| P2093 | author name string | Carlos Moneriz | |
| P2860 | cites work | Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria | Q37686622 |
| Empowering malaria vaccination by drug administration | Q37740562 | ||
| Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum | Q39362892 | ||
| Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage | Q41337172 | ||
| Protection against a malaria challenge by sporozoite inoculation | Q41937865 | ||
| Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice | Q41943456 | ||
| Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice. | Q41943841 | ||
| Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii. | Q43074868 | ||
| Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial | Q43947975 | ||
| Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis | Q47867346 | ||
| IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice | Q47898035 | ||
| A merozoite vaccine effective against Plasmodium knowlesi malaria | Q47939749 | ||
| Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages | Q21034076 | ||
| Acquired immunity to malaria | Q24651173 | ||
| Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites | Q28212476 | ||
| Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells | Q33321082 | ||
| Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria | Q33769200 | ||
| Host defenses in murine malaria: immunological characteristics of a protracted state of immunity to Plasmodium yoelii | Q33897628 | ||
| Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria | Q33944265 | ||
| Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection. | Q34000140 | ||
| Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria | Q34004922 | ||
| Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria | Q35546069 | ||
| Innate immunity to malaria | Q35708817 | ||
| Antimalarial drug discovery: efficacy models for compound screening | Q35790381 | ||
| Antimalarial drugs - what is in use and what is in the pipeline | Q37093752 | ||
| Recent insights into humoral and cellular immune responses against malaria | Q37291684 | ||
| P921 | main subject | Plasmodium yoelii | Q12065970 |
| P304 | page(s) | 103 | |
| P577 | publication date | 2011-04-25 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice | |
| P478 | volume | 10 |
| Q38848331 | A systematic review of pentacyclic triterpenes and their derivatives as chemotherapeutic agents against tropical parasitic diseases |
| Q41927043 | Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii |
| Q37509729 | Differential immune response associated to malaria outcome is detectable in peripheral blood following Plasmodium yoelii infection in mice |
| Q26904573 | In vitro inhibitory effects of plant-derived by-products against Cryptosporidium parvum |
| Q42374556 | In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts |
| Q30386961 | In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria. |
| Q64231998 | Maslinic Acid Enhances Immune Responses in Leukemic Mice Through Macrophage Phagocytosis and Natural Killer Cell Activities |
| Q90567980 | Maslinic acid suppresses macrophage foam cells formation: Regulation of monocyte recruitment and macrophage lipids homeostasis |
| Q38237160 | Maslinic acid, a natural phytoalexin-type triterpene from olives--a promising nutraceutical? |
| Q42732002 | Multi-targeted activity of maslinic acid as an antimalarial natural compound |
Search more.